Xanadu Bio
PrivateLast Round
Series B
Aug 27, 2025
Total Funding Raised
$22.99M
Company Overview
Xanadu Bio is a biotechnology company that develops a biodegradable poly(amine-co-ester) nanoparticle delivery platform for mRNA and other nucleic acid therapeutics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Xanadu Bio Comparables
Compare Xanadu Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Stradefy Biosciences | 83% | |
| Nanite, Inc. | 83% | |
| 20Med Therapeutics | 80% |
Xanadu Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Aug 27, 2025 | ||||
| Series A | Aug 16, 2022 |
Key People
Founding team and executive leadership
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 27, 2025
$11M round completed.
- May 1, 2025
Monthly visitors increased 158% MoM, reaching 2.1K.
Xanadu Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Xanadu Bio's valuation, stock price, and market status.
Is Xanadu Bio a public or private company?
Xanadu Bio is a private company.
What is the current stock price of Xanadu Bio?
Xanadu Bio is a private company with no public stock price. Caplight tracks Xanadu Bio's secondary market activity and provides MarketPrice estimates to Caplight users.
How much is Xanadu Bio worth (valuation)?
Valuation information for Xanadu Bio is not publicly available.
Can I buy Xanadu Bio stock?
Xanadu Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Xanadu Bio's last funding round?
Xanadu Bio's most recent funding round was Series B on August 27, 2025.
Who are the main investors in Xanadu Bio?
Investor information for Xanadu Bio is not publicly disclosed.
Will Xanadu Bio IPO soon?
No public IPO plans have been announced for Xanadu Bio.
How can I track Xanadu Bio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Xanadu Bio's secondary market activity and sign up for updates.